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ABSTRACT
Objectives To investigate the impact of gender on 
multimorbidity in northern Iran.
Design A cross-sectional analysis of the Golestan cohort 
data.
Setting Golestan Province, Iran.
Study population 49 946 residents (age 40–75 years) of 
Golestan Province, Iran.
Main outcome measures Researchers collected data 
related to multimorbidity, defined as co-existence of two 
or more chronic diseases in an individual, at the beginning 
of a representative cohort study which recruited its 
participants from 2004 to 2008. The researchers utilised 
simple and multiple Poisson regression models with robust 
variances to examine the simultaneous effects of multiple 
factors.
Results Women had a 25.0% prevalence of 
multimorbidity, whereas men had a 13.4% prevalence 
(p<0.001). Women of all age-groups had a higher 
prevalence of multimorbidity. Of note, multimorbidity began 
at a lower age (40–49 years) in women (17.3%) compared 
with men (8.6%) of the same age (p<0.001). This study 
identified significant interactions between gender as 
well as socioeconomic status, ethnicity, physical activity, 
marital status, education level and smoking (p<0.01).
Conclusion Prevention and control of multimorbidity 
requires health promotion programmes to increase public 
awareness about the modifiable risk factors, particularly 
among women.
INTRODUCTION
Chronic diseases not only induce phys-
ical complications and social hardships for 
patients, but also present a heavy burden for 
healthcare systems. This issue can be further 
intensified by multimorbidity, the simulta-
neous occurrence of two or more chronic 
diseases in one person.1–3 Multimorbidity is 
associated with a higher mortality risk and 
increased utilisation of healthcare services; 
therefore, it is a demanding situation for 
patients, their families and healthcare 
providers.4–8
Despite the increase in life expectancy 
among lower and middle income coun-
tries over the last decades, the growing 
prevalence of multimorbidity has led to 
a decreased quality of life in patients with 
chronic diseases, especially in populations 
with limited resources.9 10 Patients with 
multimorbidity require specific medical 
care; however, the current clinical practice 
lacks practical guidelines to manage and 
treat these patients.11–14 Current clinical 
practices for patients with multiple chronic 
diseases routinely deal with each individual 
disease rather than multiple diseases, and 
can result in increased expenses for patients 
Strengths and limitations of this study
 ► This is a large, population-based cross-
sectional study, with detailed data provided  on 
sociodemographic, lifestyle and behavioural risk 
factors.
 ► Trained, qualified medical researchers collected all 
of the data by interactive face-to-face interviews.
 ► Cross-sectional data analyses are susceptible to 
residual confounding and cannot determine the 
direction of an association.
 ► Another limitation of this investigation was possible 
recall bias resulting from the method of gathering 
medical history (self-report).
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and healthcare systems, and possibly lead to unwanted 
adverse effects.13 15 16
Previous studies have shown a gender difference in 
patterns of multimorbidity. A systematic review of most 
previous studies indicated that women had a greater 
prevalence of multimorbidity compared with men.17 This 
difference might be related to biological, sociocultural, 
environmental or economic factors. As these factors vary 
globally, their associations with multimorbidity might 
differ across populations.18–22 Therefore, more research 
should be conducted on this topic.
We used baseline data from the Golestan Cohort Study 
(GCS), a large-scale prospective study in Western Asia, 
to explore the epidemiology of multimorbidity.23 In this 
article we used detailed statistical analyses to examine 
the variability of the prevalence and determinants of 
multimorbidity among different age groups. We also 
investigated interactions between gender and multiple 
sociodemographic and lifestyle factors potentially associ-
ated with multimorbidity.
METHODS
This cross-sectional study analysed baseline data from the 
GCS. We analysed data from 49 946 Iranians, aged 40–75 
years, who resided in Golestan Province in northeastern 
Iran. Participants had no current or previous diagnosis of 
any upper gastrointestinal cancers. The original cohort 
recruited its participants from 2004 to 2008.24 The details 
of this study have been described elsewhere.23
Body mass index (BMI) was defined as underweight 
(<18.5 kg/m2), normal (18.5–24.9 kg/m2), overweight 
(25–29.9 kg/m2), and obese (>30 kg/m2). We divided 
participants into the following age clusters (age at the 
time of the interviews): 40–49, 50–60, and 61–75 years. In 
this mainly rural population, physical activity was defined 
based on occupational activity as follows: physically 
active (heavy or intense activity during employment) or 
physically inactive (all other participants). Participants’ 
socioeconomic status (SES) comprised three levels (low, 
middle or high) according to the two-step cluster anal-
ysis25 with the use of similarities for family assets, ethnicity, 
sex, employment status, age at onset of the first job, home 
ownership status and house size (surface area), and age.
Based on the possibility of gathering valid self-reported 
data during the feasibility phase of the GCS, we collected 
self-reported information for the following chronic 
diseases: cardiovascular disease, diabetes (types I and II), 
chronic obstructive pulmonary disease, chronic kidney 
disease, chronic liver disease, tuberculosis, gastro-oesoph-
ageal reflux disease (GORD), and cancers.24 Respondents 
reported the presence of regurgitation or heartburn 
during the past 1–2 years, via a standard GORD ques-
tionnaire.26 27 Participants who reported any symptoms 
during the mentioned time period were considered to 
have GORD.
In this study, we defined multimorbidity as the simulta-
neous occurrence of two or more of the above mentioned 
chronic diseases (non-acute conditions)23 in the same 
person.7 8 28
Statistical analysis
We estimated multimorbidity among participants 
according to several sociodemographic and lifestyle 
factors. The Student’s t-test, Mann-Whitney or χ2 tests 
evaluated differences in the distribution of respondents 
according to sociodemographic factors and lifestyle 
factors between men and women whenever appropriate.
Occasions exist in which the OR can be misleading. 
Hence, we have used a model that could provide the 
prevalence ratio. Simple and multiple Poisson regres-
sions were used with robust variances according to the 
method presented by Barros and Hirakata.29 We sought 
to examine the possibility of a gender-based association 
between the studied factors and multimorbidity, calcu-
lated crude and adjusted prevalence ratios and tested it 
with the interaction (effect modification) test, and 95% 
CIs. The gender differences between determinants of 
multimorbidity (ie, interaction or effect modification) 
were evaluated in separate multiple Poisson regression 
models.
We have considered the design effects according to 
the generalised estimating equations method for all anal-
yses. This method is a generalisation of the generalized 
linear model (GLM) that can handle the correlation of 
observation. The assumption of the GLM is the indepen-
dence of observation which could be violated in studies 
that have intra-cluster correlations in cluster sampling 
or randomisation, as well as in longitudinal analysis of 
repeated measurements obtained from a subject.30 31 All 
statistical analyses were performed using SPSS software 
(IBM Corporation, released 2013, IBM SPSS Statistics 
for Windows, version 22.0; Armonk, New York, USA). 
Two-sided p-values <0.05 were considered statistically 
significant.
RESULTS
This cross-sectional study enrolled 49 946 participants 
(aged 40–75 years) who predominantly resided in rural 
areas. Women comprised 28 748 (57.6%) participants. 
The Supplementary table shows the prevalence of self-re-
ported chronic diseases in those with multimorbidity and 
the gender differences.
The results indicated an overall age-sex standardised 
prevalence for multimorbidity of 19.4% (95% CI 19.1% to 
19.8%). Women had almost twice the prevalence (25.0%) 
compared with men (13.4%), with a difference of 11.7% 
(95% CI 11.0% to 12.4%) (p <0.001). Table 1 shows the 
prevalence of multimorbidity in all study participants 
according to gender, sociodemographic and lifestyle 
factors. Women had evidence of more multimorbidity in 
all age groups. Of note, compared with men, multimor-
bidity in women began at an earlier age (40–49 years). 
In this age group, 17.3% of women had multimorbidity 
compared with 8.6% for men (p <0.001).
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Table 2 shows the results from multiple Poisson regres-
sion models. Men who were ex-smokers, non-Turkmen, 
married and physically inactive had a significantly higher 
chance of multimorbidity. Being in lower socioeconomic 
groups showed an association with multimorbidity only in 
women. Higher educational levels (compared with illit-
eracy) showed an inverse association with multimorbidity, 
mainly in women (p<0.001). Based on interaction anal-
ysis, a significantly stronger association existed between 
poor/middle SES with multimorbidity in women 
compared with men (p=0.033). The associations between 
non-Turkmen ethnicity groups (p=0.003), married status 
(p=0.041), physical inactivity (p=0.009) and ex- smoking 
(p=0.033) and the prevalence of multimorbidity was 
statistically significant in men only, or stronger in men 
compared with women. There was an inverse association 
between education and multimorbidity mainly in women 
(p for interaction <0.001).
DISCUSSION
This study examined gender-related determinants of 
multimorbidity in a cross-sectional analysis of a large 
cohort study that had more than 49 000 participants. 
Women of all ages had a higher overall prevalence of 
multimorbidity. Multimorbidity was not only prevalent 
in elderly people, it also affected participants aged 40–49 
years. Gender interacted with sociodemographic factors 
of ethnicity, marital status, educational level, SES, physical 
activity and smoking in terms of multimorbidity preva-
lence. Past smoking history, non-Turkmen ethnic groups, 
married status and physical inactivity showed significant 
associations with multimorbidity in men. Lower socio-
economic groups were associated with multimorbidity, 
but only in women.
Despite current perceptions, this study revealed that 
multimorbidity was not confined to elderly people. 
The results showed that middle-age cohort participants 
(age <50) of both genders also suffered from this condi-
tion, and this observation has been supported by another 
study.32 We observed that women had a greater burden of 
multimorbidity which supported the results from a study 
by Zielinski et al on a Swedish population.33 A potential 
cause for more significant prevalence of multimorbidity 
among women could be their relatively higher tendency 
to share their conditions in self-reports.34 35 There is 
evidence that women use more healthcare facilities, 
particularly public funded healthcare, compared with 
men.36–38 Possible influences for this excess multimor-
bidity in women could be higher exposure to common 
risk factors for chronic diseases or gender inequality in 
access to healthcare.7 8 39–42 It is worth mentioning that 
this information is related to data collected approxi-
mately 10 years ago at a subnational level.
This study showed a significant association between 
low SES and multimorbidity among women, a finding 
suggested by earlier studies.43 44 This might partially be 
explained by differences in lifestyle attributed to SES. Low V
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SES might reduce care-seeking in patients with chronic 
diseases.43 This might produce a paradox, as lower health-
care use might translate to lower documented morbidity. 
This study’s findings indicated that low and middle SES 
had an association with multimorbidity in women, which 
has supported the assertion that women are at higher risk 
from the adverse effects of poverty, payment inequality and 
health disparities.45 Khanam et al concluded that gender 
differences in SES, living and working environments, life-
style factors and life-events might affect the occurrence 
and outcome of multimorbidity among women.46
A previous study revealed that inactivity might increase 
the risk of breast and colorectal cancers, diabetes mellitus 
and ischaemic heart diseases.47 Autenrieth et al discov-
ered an inverse association between physical activity and 
multimorbidity among men.35 Another study reported no 
association between multimorbidity and physical activity 
for either men or women.48 We observed an association 
between sedentary occupations that involved decreased 
physical activity and multimorbidity, which was more 
evident in men. This might be due to the proportionately 
longer hours that men spend in sedentary occupations.
In this study the prevalence ratio of multimorbidity 
significantly decreased with increased education level; 
the association was more obvious in women. Similarly, 
other studies showed a decreased likelihood of multimor-
bidity among better-educated populations.39 42 49
The GCS enrolled participants above 40 years of age 
whose cultural, educational and social basis was shaped 
around the 1970s – a time of limited access to primary 
healthcare facilities, particularly in rural areas.50 However, 
after the 1980s, there was a substantial improvement in 
health, life expectancy, control of communicable diseases 
and SES in Iran.25 50 Iran was among the few countries 
that reached WHO defined millennium development 
goals before 2015.51 We observed that education was 
defined as a protective factor for multimorbidity. In this 
population, women had a literacy rate below 20%.24 The 
latest report, released in 2014, has shown a tremendous 
increase in women’s literacy in Golestan Province, which 
is over 80%.52 The improvements in health, education 
and other SES have decreased health inequalities which 
may influence disease patterns, including multimorbidity, 
in succeeding generations.
Access to affordable health services, as a human right, 
is a necessity for improved quality of life. Despite the 
considerable progress in community health in recent 
decades, there is an increasing prevalence of chronic 
diseases.53 Some global movements related to healthy 
lifestyles have underlined the need for multi-dimension-
ality collaborations for health promotion as stated in the 
Ottawa Charter.53–57 The findings of this study and recom-
mendations by WHO53 indicate that specific national 
and sub-national health policies for men and women of 
different age groups and SES should be implemented.
The possible changes in demographic characteristics 
and lifestyle habits of the Iranian population over the 
past decades and the current study sampling methods V
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(regional vs national) should be taken into consideration. 
Future studies that assess more representative samples or 
at the national level are recommended.
CONCLUSION
The findings of this study confirm that multimorbidity 
is an important health issue for all individuals above 40 
years of age, with particular emphasis on women with 
lower SES and educational levels. Men with decreased 
physical activity who are married and are former smokers 
also have a higher risk for multimorbidity.
Defining priority interventions and multisectorial poli-
cies that tackle multimorbidity in both men and women, 
as well as focusing increased attention on middle-aged 
populations, are required. In order to control multimor-
bidity, particularly in women, we recommend the use of 
health promotion and educational methods to enhance 
public awareness about modifiable risk factors such as 
physical activity and smoking.
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